Showing results (531-540 of 2,814) with videos related to

Sort By:
Pageof 282
Diabetes Technology & Therapeutics|March 3, 2022
High-Throughput Multiplex Electrochemiluminescence Assay Applicable to General Population Screening for Type 1 Diabetes and Celiac DiseaseLing He, Xiaofan Jia, Cristy Geno Rasmussen, et al.
Diabetes Technology & Therapeutics|March 7, 2022
Automated Insulin Delivery with SGLT2i Combination Therapy in Type 1 DiabetesJose Garcia-Tirado, Leon Farhy, Ralf Nass, et al.
Diabetes Technology & Therapeutics|March 1, 2022
Association Between Real-Time Continuous Glucose Monitor Use and Diabetes-Related Medical Costs for Patients with Type 2 DiabetesGregory J Norman, Misti L Paudel, Christopher G Parkin, et al.
Diabetes Technology & Therapeutics|June 1, 2019
Comparative Dose Accuracy of Durable and Patch Insulin Pumps Under Laboratory ConditionsKatharina Laubner, Eva Singler, Jan Straetener, et al.
Diabetes Technology & Therapeutics|September 21, 2021
Insurance Coverage for Emerging Diabetes Technologies: Payers' PerspectiveTim Nolan, Marie Frazzitta
Diabetes Technology & Therapeutics|September 21, 2021
Integrating Continuous Glucose Monitoring Into Clinical Practices and Patients' LivesIrl B Hirsch, Eden Miller
Diabetes Technology & Therapeutics|September 21, 2021
Health Care Disparities in Use of Continuous Glucose MonitoringDiana Isaacs, Natalie J Bellini, Ursula Biba, et al.
Diabetes Technology & Therapeutics|January 20, 2010
The role of basal insulin and glucagon-like peptide-1 agonists in the therapeutic management of type 2 diabetes--a comprehensive reviewSatish K Garg
Diabetes Technology & Therapeutics|January 20, 2010
Attitudes towards insulin pump therapy among adolescents and young peopleSabine Seereiner, Kurt Neeser, Christian Weber, et al.
Diabetes Technology & Therapeutics|January 29, 2010
Timing of bolus in children with type 1 diabetes using continuous subcutaneous insulin infusion (TiBoDi Study)Andrea E Scaramuzza, Dario Iafusco, Laura Santoro, et al.
Pageof 282